9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 101 filers reported holding 9 METERS BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $22,000 | -24.1% | 102,678 | -10.9% | 0.00% | – |
| Q2 2022 | $29,000 | -51.7% | 115,265 | +16.7% | 0.00% | – |
| Q1 2022 | $60,000 | -47.4% | 98,733 | -15.8% | 0.00% | – |
| Q4 2021 | $114,000 | -3.4% | 117,241 | +30.3% | 0.00% | – |
| Q3 2021 | $118,000 | -90.8% | 89,968 | -92.3% | 0.00% | – |
| Q2 2021 | $1,289,000 | +2084.7% | 1,172,254 | +2229.4% | 0.00% | – |
| Q1 2021 | $59,000 | +1080.0% | 50,324 | +815.0% | 0.00% | – |
| Q4 2020 | $5,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 2,750,000 | $3,575,000 | 1.04% |
| ODonnell Financial Services, LLC | 840,727 | $1,093,000 | 0.52% |
| Orbimed Advisors | 8,565,974 | $11,136,000 | 0.12% |
| Paradigm, Strategies in Wealth Management, LLC | 30,800 | $40,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 15,000,000 | $19,500,000 | 0.04% |
| Ascent Wealth Partners, LLC | 85,224 | $111,000 | 0.02% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 475,839 | $619,000 | 0.02% |
| Prentice Wealth Management LLC | 29,000 | $38,000 | 0.02% |
| Valeo Financial Advisors, LLC | 198,148 | $258,000 | 0.02% |
| Almanack Investment Partners, LLC. | 40,850 | $53,000 | 0.01% |